- 1.
Referansegruppen for Nasjonal kompetansetjeneste for bevegelsesforstyrrelser. Revidert terapianbefaling ved Parkinsons sykdom. https://helse-stavanger.no/seksjon/NKB/Documents/Nyhetsbulletin/Nyhetsbulletin%202014%20-%20nr.%202.pdf Lest 12.2.2023.
- 2.
Deutsche Gesellschaft für Neurologie. Idiopathisches Parkinson-Syndrom. Leitlinien für Diagnostik und Therapie in der Neurologie. Https://dnvp9c1uo2095.cloudfront.net/wp-content/uploads/2013/01/030010_LL_kurzfassung_ips_2016.pdf Lest 12.2.2023.
- 3.
Socialstyrelsen. Nationella riktlinjer för vård vid multipel skleros och Parkinsons sjukdom. Stöd för styrning och ledning. Stockholm: Socialstyrelsen, 2016.
- 4.
UK NICE Guideline. Parkinson's disease in adults. www.nice.org.uk/guidance/ng71 Lest 12.2.2023.
- 5.
Postuma RB, Berg D, Stern M et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015; 30: 1591–601. [PubMed][CrossRef]
- 6.
Müller B, Larsen JP, Wentzel-Larsen T et al. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord 2011; 26: 65–72. [PubMed][CrossRef]
- 7.
Tysnes OB, Vilming ST. Atypisk parkinsonisme. Tidsskr Nor Lægeforen 2008; 128: 2077–80. [PubMed]
- 8.
Larsen JP, Boas J, Erdal JE. Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. Eur J Neurol 1999; 6: 539–47. [PubMed][CrossRef]
- 9.
Fahn S, Oakes D, Shoulson I et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498–508. [PubMed][CrossRef]
- 10.
Bjørnestad A, Forsaa EB, Pedersen KF et al. Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Parkinsonism Relat Disord 2016; 22: 48–53. [PubMed][CrossRef]
- 11.
Rascol O, Brooks DJ, Korczyn AD et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000; 342: 1484–91. [PubMed][CrossRef]
- 12.
Dietrichs E, Odin P. Algorithms for the treatment of motor problems in Parkinson's disease. Acta Neurol Scand 2017; 136: 378–85. [PubMed][CrossRef]
- 13.
Erga AH, Alves G, Larsen JP et al. Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study. J Parkinsons Dis 2017; 7: 183–91. [PubMed][CrossRef]
- 14.
Giladi N, Gurevich T, Djaldetti R et al. ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study. Parkinsonism Relat Disord 2021; 91: 139–45. [PubMed][CrossRef]
- 15.
Bjerknes S, Toft M, Brandt R et al. Subthalamic nucleus stimulation in Parkinson's disease: 5-year extension study of a randomized trial. Mov Disord Clin Pract (Hoboken) 2021; 9: 48–59. [PubMed][CrossRef]
- 16.
Kvernmo N, Konglund AE, Reich MM et al. Deep brain stimulation for arm tremor. Ann Neurol 2022; 91: 585–601. [PubMed][CrossRef]
- 17.
Moosa S, Martínez-Fernández R, Elias WJ et al. The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease. Mov Disord 2019; 34: 1243–51. [PubMed][CrossRef]
()